Skip to main content
Caplight Logo









Daye

Daye

Private
LondonHealthcare & Life Scienceshttps://www.yourdaye.com/

Last Round

Series A

Oct 26, 2022

Total Funding Raised

$17.12M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Daye is a gynecological health company that develops innovative products and services, including CBD-infused tampons and at-home diagnostic testing kits, to address gaps in women's health.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Telemedicine, Subscription Commerce

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

femtechgynecological healthmedical-grade tamponwomen's health techat-home diagnostic kitsSTI testingvaginal microbiome screeningmenstrual healthdirect-to-consumer healthperiod careDTCreproductive healthtelemedicinesubscription health productsclinical diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Daye Comparables

Compare Daye with similar companies based on industry and business-model similarity.

Daye comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hertility
78%
Evvy
77%
Teal Health
76%

Daye Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 26, 2022
SeedMay 1, 2019

Key People

Founding team and executive leadership

Valentina Milanova

Founder & CEO CPO

Founding Team

Ed Cousins

Chief Technology Officer

Executive Team

Daye Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 5, 2025

    Launched 'Hormonal Testing from Home' service.

  • Nov 5, 2025

    Over 100,000 users now trust their products.

Daye Filings

Explore SEC and related filing metadata, where available.

Daye filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Daye's valuation, stock price, and market status.

Is Daye a public or private company?

Daye is a private company.

What is the current stock price of Daye?

Daye is a private company with no public stock price. No recent secondary market data is available.

How much is Daye worth (valuation)?

Valuation information for Daye is not publicly available.

Can I buy Daye stock?

Daye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Daye's last funding round?

Daye's most recent funding round was Series A on October 26, 2022.

Who are the main investors in Daye?

Key investors in Daye include MassMutual Ventures, Hambro Perks Ltd..

Will Daye IPO soon?

No public IPO plans have been announced for Daye.

How can I track Daye secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Daye's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range37
Year Founded2017
Last FundingOct 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?